Biogen Inc (BIIB) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NASDAQ

Key Metrics

• Price: $188.02
• Market Cap: $27.99B
• P/E Ratio: 22.23
• EPS: $8.58
• 52-Week High: $202.41
• 52-Week Low: $110.04

Market Sentiment

Biogen Inc currently has a Bullish sentiment score of 0.17.

About Biogen Inc

Biogen Inc. is a premier American biotechnology company headquartered in Cambridge, Massachusetts, specializing in the discovery and development of transformative therapies for neurological disorders. With a robust pipeline targeting critical conditions like multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy, Biogen is at the forefront of addressing significant unmet medical needs. The company is dedicated to advancing therapeutic innovation and enhancing patient outcomes th...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Biogen Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BIIB pay dividends?

Biogen Inc (BIIB) does not currently pay a regular dividend.

What is BIIB's P/E ratio?

Biogen Inc has a price-to-earnings (P/E) ratio of 22.23.

What is BIIB's market cap?

Biogen Inc (BIIB) has a market capitalization of $27.99B with a current stock price of $188.02.